Expertise in
13
conditions

Dr. Mark B. Yagan

Pulmonary Medicine | Intensive Care Medicine
Saint Lukes Physician Group Inc
4321 Washington St, Suite 6000, 
Kansas City, MO 
Accepting New Patients
Offers Telehealth
Expertise in
13
conditions
Saint Lukes Physician Group Inc
4321 Washington St, Suite 6000, 
Kansas City, MO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mark Yagan is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Kansas City, Missouri. Dr. Yagan is highly rated in 13 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Pulmonary Veno-Occlusive Disease, Lymphangioleiomyomatosis, and Chronic Cough. Dr. Yagan is currently accepting new patients.

His clinical research consists of participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pulmonary Medicine
Intensive Care Medicine
Licenses
Critical Care Medicine in MO
Hospital Affiliations
Saint Luke's East Hospital
Saint Luke's South Hospital
St Lukes Hospital Of Kansas City
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Home State Health
  • EPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sunflower Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

SAINT LUKES PHYSICIAN GROUP INC
4321 Washington St, Suite 6000, Kansas City, MO 64111
Other Locations
SAINT LUKES PHYSICIAN GROUP INC
1001 6th Ave, Suite 340, Leavenworth, KS 66048
SAINT LUKES PHYSICIAN GROUP INC
601 S 169 Hwy, Smithville, MO 64089

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials
Similar Doctors
Expertise in
8
conditions
Dr. Scott M. Matson
Intensive Care Medicine | Pulmonary Medicine
Expertise in
8
conditions
Dr. Scott M. Matson
Intensive Care Medicine | Pulmonary Medicine

Kansas University Physicians Inc

3901 Rainbow Blvd, 
Kansas City, KS 
 (1.2 miles away)
913-588-7775
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Scott Matson is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Kansas City, Kansas. Dr. Matson is highly rated in 8 conditions, according to our data. His top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Rheumatoid Lung Disease, and Pulmonary Fibrosis. Dr. Matson is currently accepting new patients.

Expertise in
17
conditions
Dr. Mark J. Hamblin
Pulmonary Medicine
Expertise in
17
conditions
Dr. Mark J. Hamblin
Pulmonary Medicine

Kansas University Physicians Inc

4000 Cambridge St, 
Kansas City, KS 
 (1.0 miles away)
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Hamblin is a Pulmonary Medicine provider in Kansas City, Kansas. Dr. Hamblin is highly rated in 17 conditions, according to our data. His top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Sarcoidosis, and Bone Marrow Aspiration. Dr. Hamblin is currently accepting new patients.

Expertise in
5
conditions
Dr. Matthias A. Salathe
Pulmonary Medicine | Intensive Care Medicine
Expertise in
5
conditions
Dr. Matthias A. Salathe
Pulmonary Medicine | Intensive Care Medicine

Kansas University Physicians Inc

4000 Cambridge St, 
Kansas City, KS 
 (1.0 miles away)
913-588-1227
Languages Spoken:
English, French, German
See accepted insurances
Accepting New Patients

Matthias Salathe is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Kansas City, Kansas. Dr. Salathe is highly rated in 5 conditions, according to our data. His top areas of expertise are Cystic Fibrosis, Bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), and Respiratory Syncytial Virus (RSV) Infection. Dr. Salathe is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Yagan's expertise for a condition
ConditionClose
    View All 11 Advanced Conditions
    View All 21 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile